Current studentsExisting staffContact us
 

The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice

Simple item page
dc.contributor.authorYang, Y.
dc.contributor.authorAhn, Y.
dc.contributor.authorGibbons, D.
dc.contributor.authorZang, Y.
dc.contributor.authorLin, W.
dc.contributor.authorThilaganathan, N.
dc.contributor.authorAlvarez, C.
dc.contributor.authorMoreira, D.
dc.contributor.authorCreighton, C.
dc.contributor.authorGregory, P.
dc.contributor.authorGoodall, G.
dc.contributor.authorKurie, J.
dc.date.issued2011
dc.description.abstractEpithelial tumor cells transit to a mesenchymal state in response to extracellular cues, in a process known as epithelial-to-mesenchymal transition (EMT). The precise nature of these cues has not been fully defined, an important issue given that EMT is an early event in tumor metastasis. Here, we have found that a population of metastasis-prone mouse lung adenocarcinoma cells expresses Notch and Notch ligands and that the Notch ligand Jagged2 promotes metastasis. Mechanistically, Jagged2 was found to promote metastasis by increasing the expression of GATA-binding (Gata) factors, which suppressed expression of the microRNA-200 (miR-200) family of microRNAs that target the transcriptional repressors that drive EMT and thereby induced EMT. Reciprocally, miR-200 inhibited expression of Gata3, which reversed EMT and abrogated metastasis, suggesting that Gata3 and miR-200 are mutually inhibitory and have opposing effects on EMT and metastasis. Consistent with this, high levels of Gata3 expression correlated with EMT in primary tumors from 2 cohorts of lung adenocarcinoma patients. These findings reveal what we believe to be a novel Jagged2/miR-200–dependent pathway that mediates lung adenocarcinoma EMT and metastasis in mice and may have implications for the treatment of human epithelial tumors.
dc.description.statementofresponsibilityYanan Yang, Young-Ho Ahn, Don L. Gibbons, Yi Zang, Wei Lin, Nishan Thilaganathan, Cristina A. Alvarez, Daniel C. Moreira, Chad J. Creighton, Philip A. Gregory, Gregory J. Goodall and Jonathan M. Kurie
dc.identifier.citationJournal of Clinical Investigation, 2011; 121(4):1373-1385
dc.identifier.doi10.1172/JCI42579
dc.identifier.issn0021-9738
dc.identifier.issn1558-8238
dc.identifier.orcidGregory, P. [0000-0002-0999-0632]
dc.identifier.orcidGoodall, G. [0000-0003-1294-0692]
dc.identifier.urihttp://hdl.handle.net/2440/66874
dc.language.isoen
dc.publisherAmer Soc Clinical Investigation Inc
dc.rightsCopyright © 2011, American Society for Clinical Investigation
dc.source.urihttps://doi.org/10.1172/JCI42579
dc.subjectJagged2
dc.subjectepithelial-to-mesenchymal transition (EMT)
dc.subjecttumor metastasis
dc.titleThe Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice
dc.typeJournal article
pubs.publication-statusPublished

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
hdl_66874.pdf
Size:
5.97 MB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections

Molecular and Biomedical Science publications